# US 2026/0272654 A1 · Transcatheter system and method for reducing tricuspid regurgitation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0272654 A1
- Document ID: US20260272654A1
- Status: Published application
- Kind: A1
- Application number: 19/672,460
- Filed: 2026-05-08
- Published: 2026-09-17
- Earliest claimed: 2020-02-20
- Assignees: Tau Medical Inc.
- Applicants: Tau Medical Inc
- Inventors: June-Hong Kim
- Web page: https://patentgrep.com/patent/US20260272654A1

## CPC

- A61F 2/2466: {Delivery devices therefor}
- A61F 2/2451: {Inserts in the coronary sinus for correcting the valve shape}
- A61F 2/2487: {Devices within the heart chamber, e.g. splints}
- A61F 2230/008: paraboloidal
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The present invention relates to a system and method for transcatheter treatment for tricuspid regurgitation. The system for transcatheter treatment for tricuspid regurgitation, according to one preferred embodiment of the present invention, includes: the coronary sinus tube inserted into the coronary sinus; and the tricuspid valve tube traversing the tricuspid valve, wherein the coronary sinus tube and the tricuspid valve tube communicate with each other or are adjacent to each other within a range of predetermined length at an upper side and are separate from each other at a lower side, and a blocking member for blocking a space generated by incomplete closing of the tricuspid valve is provided at a lower part of the tricuspid valve tube or between the coronary sinus tube and the tricuspid valve tube.

## Claims

### Claim 1

A method of treating tricuspid valve regurgitation in a patient’s heart, comprising:
having a cerclage filament;
having a sleeve tube comprising;
(a) a main segment;
(b) a coronary sinus leg;
(c) a tricuspid valve leg; (d) a spacer body mounted on the tricuspid valve leg;
wherein the tricuspid valve leg is longer than the coronary sinus leg;
wherein the main segment is longer than the tricuspid valve leg and longer than the coronary sinus leg;
making a vascular entry site into an entry vein;
inserting the cerclage filament through the vascular entry site and entry vein, and further into the patient’s heart such that it takes a path into a right atrium, through a coronary sinus, through a great cardiac vein, out into a right ventricle, through a tricuspid valve, back into the right atrium, back through the entry vein, and exit back out of the vascular entry site;
sliding the sleeve tube onto the cerclage filament;
advancing the sleeve tube towards the patient’s right atrium;
positioning the spacer body between leaflets of the patient’s tricuspid valve;
creating a locked cerclage loop by fastening together an entry segment of the cerclage filament to an opposing return segment of the cerclage filament, wherein the fastening together occurs at a location outside the right atrium.

### Claim 2 (depends on 1)

The method of claim 1, wherein the path of the cerclage filament also includes a septal perforator vein of the patient.

### Claim 3 (depends on 1)

The method of claim 1, further comprising the steps of:
inserting a guidewire through the vascular entry site and advancing the guidewire into the right atrium of the patient;
inserting a distal end of the guidewire into the coronary sinus of the patient;
advancing the guidewire and exiting the distal end of the guidewire into the right ventricle of the patient;
grasping the guidewire and pulling the distal end of the guidewire out of the entry vein;
exchanging the guidewire with the cerclage filament such that the cerclage filament takes the path through the patient’s heart.

### Claim 4 (depends on 3)

The method of claim 3, wherein the step of exchanging the guidewire with the cerclage filament comprises attaching a distal end of the cerclage filament to a proximal end of the guidewire and pulling the guidewire out such that the cerclage filament follows the path created by the guidewire.

### Claim 5 (depends on 1)

The method of claim 1, wherein the entry vein is a femoral vein and the cerclage filament passes through an inferior vena cava of the patient.

### Claim 6 (depends on 5)

The method of claim 5, wherein the fastening together occurs at a location in the inferior vena cava at a position superior to a renal vein of the patient.

### Claim 7 (depends on 5)

The method of claim 5, wherein a proximal end of the sleeve tube terminates at a location in the inferior vena cava at a position superior to a renal vein of the patient.

### Claim 8 (depends on 1)

The method of claim 1, further comprising the steps of:
sliding the coronary sinus leg over one of the entry segment or the return segment of the cerclage filament;
sliding the tricuspid valve leg over the other of the entry segment or the return segment of the cerclage filament.

### Claim 9 (depends on 1)

The method of claim 1, wherein the step of positioning the spacer body is performed while monitoring with an echocardiogram.

### Claim 10 (depends on 1)

The method of claim 1, further comprising anchoring the cerclage loop at an anchoring site in the patient’s body.

### Claim 11 (depends on 1)

The method of claim 1, wherein the step of advancing the sleeve tube comprises inserting the coronary sinus leg into the patient’s coronary sinus in the right atrium and inserting the tricuspid valve leg through the patient’s tricuspid valve.

### Claim 12 (depends on 1)

The method of claim 1, wherein the cerclage filament further comprises an overpass arch and the method further comprises the step of positioning the overpass arch inside the great cardiac vein at a position over a coronary artery.

### Claim 13 (depends on 1)

The method of claim 1, wherein the spacer body provides a coaptation surface for leaflets of the tricuspid valve.

### Claim 14 (depends on 1)

The method of claim 1, wherein the sleeve tube further comprises a stopper located at a distal end of the tricuspid valve leg, and wherein the method further comprises positioning the stopper against a wall of the right ventricle of the patient.

### Claim 15

A heart cerclage assembly comprising:
a cerclage filament having an entry segment and a return segment;
a sleeve tube comprising:
(a) a main segment;
(b) a coronary sinus leg;
(c) a tricuspid valve leg;
(d) a spacer body mounted on the tricuspid valve leg
(e) a stopper located at a distal end of the tricuspid leg;
wherein the tricuspid valve leg is longer than the coronary sinus leg; wherein the main segment is longer than the tricuspid valve leg and longer than the coronary sinus leg;
wherein the stopper is wider or has a greater diameter than the distal end of the tricuspid leg, and wherein the stopper has a width or diameter in the range of 2–6 mm;
wherein both the entry segment and the return segment travel through the main segment of the sleeve tube;
wherein one of the entry segment or the return segment travels through the coronary sinus leg of the sleeve tube;
wherein the other of the entry segment or the return segment travels through the tricuspid valve leg of the sleeve tube.

### Claim 16 (depends on 15)

The cerclage assembly of claim 15, wherein the spacer body has a curved croissant-shape with a length in the range of 20–60 mm.

### Claim 17 (depends on 15)

The cerclage assembly of claim 15, wherein the tricuspid valve leg has a length in the range of 4.0–11 cm.

### Claim 18 (depends on 15)

The cerclage assembly of claim 15, wherein the coronary sinus leg has a length in the range of 2.2–5.0 cm.

### Claim 19 (depends on 15)

The cerclage assembly of claim 15, further comprising a lock that fastens together the entry segment of the cerclage filament to an opposing return segment.

### Claim 20

A heart cerclage kit for treating tricuspid valve regurgitation, comprising:
a cerclage filament;
a sleeve tube comprising;
(a) a main segment;
(b) a coronary sinus leg;
(c) a tricuspid valve leg;
(d) a spacer body mounted on the tricuspid valve leg;
wherein the tricuspid valve leg is longer than the coronary sinus leg;
wherein the main segment is longer than the tricuspid valve leg and longer than the coronary sinus leg.
